While BRCA1, FANCG and RAD51 have previously been linked to various treatment responses in a number of cancers [31–33] limited research exists investigating the association between RT-induced regulation of these genes in radiation resistant prostate cancer. This evidence concerns the gene FANCG and prostate cancer.